Anika Therapeutics, Inc.

MA · United States · Reporting entity ID 100000010397

Total reported 2019–2025

$27.1M

#261 of 2,960 reporting companies — 0% of all reported industry payments

$24.3M in general payments across 6,395 records, plus $2.84M in research funding across 436 records.

How it breaks down

General payments $24,291,820

Research funding $2,837,848

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.